Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Ansiolin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 7 USDMF, 5 CEP/COS, 2 JDMF, 4 EU WC, 9 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

54 Drugs in Development

54 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

431 FDF Dossiers, 137 FDA Orange Book, 195 Europe, 15 Canada, 31 Australia, 18 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG, GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 2.5MG/0.5ML (5MG/ML), GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 4 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 3 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 26 Disintegrants & Superdisintegrants, 26 Direct Compression, 24 Granulation, 22 Thickeners and Stabilizers, 19 Controlled & Modified Release, 18 Lubricants & Glidants, 17 Film Formers & Plasticizers, 17 Topical, 14 Taste Masking, 11 Co-Processed Excipients, 10 Parenteral, 9 Chewable & Orodispersible Aids, 9 Solubilizers, 6 Rheology Modifiers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 78 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 111 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

PATENTS & EXCLUSIVITIES

27 US Patents, 6 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 12 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
12/12/2025	Rusan Pharma	India	RUSAN PHARMA LTD Mumbai IN	CEP 2024-260 - Rev 00	Diazepam	2025-10-10	Valid	Chemical		22
29/11/2025	Centaur Pharmaceuticals	India	CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai IN	CEP 2008-195 - Rev 05	Diazepam	2023-10-19	Valid	Chemical		22

Ansiolin

Ansiolin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers

7 USDMF

5 CEP/COS

2 JDMF

4 EU WC

9 NDC API

14 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

54 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

431 FDF Dossiers

137 FDA Orange Book

195 Europe

15 Canada

31 Australia

18 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 2MG

TABLET;ORAL - 5MG

GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)

GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

6 SPI Pharma

3 DKSH

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 ACG Worldwide

4 Actylis

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

14 BASF

1 CD Formulation

2 Clariant

10 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

3 Finar

6 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

27 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

5 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

5 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

GEL;RECTAL - 10MG/2ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 15MG/3ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 20MG/4ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 5MG/ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons